Skip to main content
Fig. 10 | Journal of Translational Medicine

Fig. 10

From: The siRNA-mediated knockdown of AP-1 restores the function of the pulmonary artery and the right ventricle by reducing perivascular and interstitial fibrosis and key molecular players in cardiopulmonary disease

Fig. 10

Representative Western blotting images of the expression levels of AP-1S3 (a), pFAK, FAK (b), pERK, ERK and β-actin/GAPDH (c) in pulmonary artery homogenates from all three experimental animal groups after 12 weeks of MCT alone or in combination with siRNA AP-1 for 10 weeks. Histograms show a quantitative representation of signalling molecules, AP-1S3 (a.1), pFAK, FAK (b.1), pERK, ERK (c.1). The data are shown as the mean ± SD of 4 independent experiments. Statistical significance represented as **P < 0.01, *P < 0.05 values versus control group and ###P < 0.005, ##P < 0.01, #P < 0.05 values versus MCT group, One-way ANOVA, Bonferroni post-test. Quantification of band intensities expressed as ratio with β-actin/GAPDH was analysed by TotalLab TL120 program. The housekeeping β-actin and GAPDH proteins are shown as loading control for protein normalization

Back to article page